MarcHaltermanMDPhD, FAHA

PubMed

• 147 citations
  Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207)
  David A. Kooby, John F. Carew, Marc W. Halterman, Jonathan E. Mack, Joseph R. Bertino
  FASEB Journal. 1999-08-01
• 72 citations
  Selective infection and cytolysis of human head and neck squamous cell carcinoma with sparing of normal mucosa by a cytotoxic herpes simplex virus type 1 (G207).
  John F. Carew, David A. Kooby, Marc W. Halterman, Howard J. Federoff, Yuman Fong
  Human Gene Therapy. 1999-07-01
• 25 citations
  The post-cardiac arrest syndrome: A case for lung-brain coupling and opportunities for neuroprotection.
  Nguyen Mai, Kathleen Miller-Rhodes, Sara A. Knowlden, Marc W. Halterman
  Journal of Cerebral Blood Flow and Metabolism. 2019-03-13

Journal Articles

• Chopper is pro death regardless of the effect of p75ICD on sensitivity to oxidative stress  
  Qazi A, Halterman MW, Mi Z., Zhang T. and NF Schor, Oxid Med Cell Longev, 1/1/2011
• The Paradoxof the Neutrophil?s Role in Tissue Injury: A review  
  SegelGB, HaltermanMWand MA Lichtman, J Leukocyte Biol, 1/1/2010
• In-tube protocol modification improves transfection rates in murine neuronal cultures  
  Halterman MW, Giuliano R, Schor NF, J Neurosci Meth, 1/1/2009
•  
  Halterman MW, Dejesus C, Rempe D, Schor NF and HJ Federoff, Mol Cell Neurosci, 1/1/2008
• Tremor in aqueductal stenosis and response to endoscopic third ventriculostomy  
  Halterman MW, Vates GE, and GH Riggs, Neurology, 1/1/2007
• An update on the use of intravenous iron for the treatment of restless leg syndrome in end stage renal disease  
  Halterman MW and JA Sloand, Expertos Invitados, SIIC, Saludi Ciencia, 1/1/2007
• Efficacy of multiagent herpessimplex virusamplicon-mediated immunotherapy as adjuvant treatment for experimental hepatic cancer  
  Delman KA, Zager JS, Bennett JJ, Malhotra S, Ebright MI, McAuliffe PF, Halterman MW, Federoff HJ, Fong Y, Ann Surg, 1/1/2002
• Combinationvasculardelivery ofherpes simplex oncolytic viruses andamplicon mediated cytokine gene transfer is effective therapy for experimental liver cancer  
  Zager JS, Delman KA, Malhotra S, Ebright MI, Bennett JJ, Kates T, Halterman M, FederoffH, Fong Y, Mol Med, 1/1/2001
• A Novel Approach to Cancer Therapy Using an Oncolytic Herpes Virus to Package Amplicons Containing Cytokine Genes  
  Carew JF, Kooby DA, Halterman MW, Kim SH, Federoff HJ, Fong Y.A, Mol Med, 1/1/2001
• Expression of vhs and VP16 during HSV-1 helper virus-free amplicon packaging enhances titers  
  Bowers WJ, Howard DF, Brooks AI, Halterman MW, Federoff HJ, Gene Therapy, 1/1/2001
• Selective infection and cytolysis of human head and neck squamous cell carcinoma with sparing of normal mucosa by a cytotoxic herpes simplex virus type 1 (G207)  
  Carew JF, Kooby DA, Halterman MW, Federoff HJ, Fong YM, Human Gene Therapy, 1/1/1999
• Lentivirus vectors using human and simian immunodeficiency virus elements  
  White SM, Renda M, Nam NY, Klimatcheva E, Zhu YH, Fisk J, Halterman M, Rimel BJ, Federoff H, Pandya S, Rosenblatt JD, Planelles V, J Virology, 1/1/1999
•  
  Halterman MW, Miller CC, and Federoff HJ, J Neuroscience, 1/1/1999
• Oncolytic viral therapy for human colorectal cancer and liver metastasis using a multi-mutated herpes simplex virus type-1 (G207)  
  Kooby DA, Carew JF, Halterman MW, Mack JE, Bertino JR, Federoff HJ, Fong YM, FASEB J, 1/1/1999
• HIF-1-alpha and p53 promote hypoxia-induced delayed neuronal death in models of CNS ischemia  
  Halterman MW and HJ Federoff, Exp Neurol, 1/1/1999
• In vivo interleukin-2 gene therapy of established tumors with herpes simplex amplicon vectors  
  D'Angelica M, Karpoff H, Halterman M, Ellis J, Klimstra D, Edelstein D, Brownlee M, Federoff H, Fong YM, Cancer Immunology, Immunotherapy, 1/1/1999
• Eradicationof pre-established lymphoma using HSV amplicon vectors  
  Kutubuddin M, Federoff HJ, Challita-Eid PM, Halterman M, Day B, Atkinson MA, Planelles V, Rosenblatt J, Blood, 1/1/1999
• Gene therapy in the inner ear: Mechanisms and clinical implications  
  Van De Water TR, Staecker H, Halterman MW and HJ Federoff, Ann NY Acad Sci, 1/1/1999
• Reproducible and efficient murine CNS gene delivery using a microprocessor-controlled injector  
  Brooks AI, Halterman MW, Chadwick CA, Davidson BL, Haak-Frendscho M, Radel C, Porter C, Federoff HJ, J Neurosci Meth, 1/1/1998
• Transduction of human trophoblast cells by replication-deficient recombinant viral vectors: the state of cellular differentiation governs virus entry  
  Parry S, Holder J, Halterman MW, Weitzman MD, Davis AR, Federoff HJ, Strauss JF, Am J Pathol, 1/1/1998
• Use of the herpes amplicon system as a vehicle for somatic gene transfer  
  Federoff HJ, Halterman MW, Brooks AI, Advanced Drug Delivery Reviews, 1/1/1997
• Join now to see all

Books/Book Chapters

• Handbook of Experimental Pharmacology: CNS Neuroprotection 
  Chapter: Developing gene-based neuroprotection strategies using herpes amplicon vectors. 
  Halterman MW and HJ FederoffEditors: FW Marcoux and DW Choi.Springer-Verlag, New York, NY2002
• The Synapse in Development, Health and Disease 
  Chapter: Molecular Modification of neural networks: altering synaptic function through the use of viral mediated gene transfer. 
  Halterman MW and Federoff HJEditors: B.W. Festoff.JAI Press, Greenwich, CT1997

Abstracts/Posters

• Lung redox state modulates neutrophil priming during systemic inflammation.
  Gates K, Mai N, Prifti L, and Halterman MW, Keystone Symposia on Neuroinflammation: Concepts, Characteristics, Consequences, Keystone, CO, 1/19/2017
• Chronic brain dysfunction driven by acute systemic inflammation. Keystone Symposia on neuroinflammation:
  Trzeciak A, Lerman Y, Mai N, Halterman M, and Kim M, Concepts, Characteristics, Consequences, Keystone, CO, 1/19/2017
• Systemic immune responses and neutrophil activation in the propagation of neuroinflammation after cerebral ischemia-reperfusion
  Mai N, Prifti L, Halterman MW, Steven R. Schwid Resident and Fellow Research Symposium, Rochester, NY, 1/1/2016
• 9-tert butyl doxycycline inhibits neuronal injury and neutrophil trafficking after global ischemia.
  Mai N, Prifti L, Halterman MW, International Stroke Conference, Los Angeles, CA, 1/1/2016
• Mitogen-Activated Protein Kinase Phosphatase 1 Exerts an Anti-Proliferative and Pro-Apoptotic Bias in GB.
  Mills B, Hansen J, and M Halterman, 20th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology, Marriott River Center Hotel, San Antonio, TX, 1/1/2015
• Neutrophil activation as a marker for systemic inflammation and CNS disease burden in post-cardiac arrest syndrome.
  Mai N, Prifti L, Halterman MW, Steven R. Schwid Resident and Fellow Research Symposium, Rochester, NY, 1/1/2015
• Priming effectof endotoxemia on neutrophil activationand systemic injury following transient global cerebral ischemia.
  Mai N, PriftiL, HaltermanMW, National MD/PhD Student Conference, Keystone, CO, 1/1/2015
• Neutrophil activation as a marker for systemic inflammation and CNS disease burden in a novel model of post-cardiac arrest syndrome.
  Mai N, Prifti L, Halterman MW, International Stroke Conference, Nashville, TN, 1/1/2015
• Mitogen-Activated Protein Kinase Phosphatase 1 Exerts an Anti-Proliferative and Pro-Apoptotic Bias in GBM.
  Mills B, Hansen J, and M Halterman, Annual Neuroscience Retreat, Memorial Art Gallery, Rochester, NY, 1/1/2015
• Priming effectof endotoxemia on neutrophil activationand systemic injury following transient global cerebral ischemia
  Mai N, PriftiL, HaltermanMW, American Physician Scientists Association North East Regional Meeting, Syracuse, NY, 1/1/2015
• Mitogen-Activated Protein Kinase Phosphatase 1 Exerts an Anti-Proliferative and Pro-Apoptotic Bias in GBM.
  Mills B, Hansen J, and M Halterman, 10th Annual Steven R. Schwid Research Symposium, University of Rochester Medical Center, Rochester, NY, 1/1/2015
• Mitogen-Activated Protein Kinase Phosphatase 1 Exerts an Anti-Proliferative and Pro-Apoptotic Bias in GBM.
  Mills B, Hansen J, and M Halterman, James P Wilmot Cancer Center Symposium, University of Rochester Medical Center, Rochester, NY, 1/1/2014
• 9-tert-butyl-doxycycline inhibits neuronal injury and neutrophil trafficking after global ischemia.
  Mai N, PriftiL, Bazarian H, RiningerA, Nelson ML, Halterman MW, Medical Scientist Research Symposium, Rochester, NY, 1/1/2014
• MKP-1 Effects on HIF-1(Inverted A) and Cell Survival in Glioblastoma Multiforme.
  Mills B, Hansen J, and M Halterman, Pathology Research Day, University of Rochester Medical Center, Rochester, NY, 1/1/2014
• NeutrophilPriming and Brain-Lung Coupling in Cerebral Ischemia-Reperfusion Injury
  Mai N, PriftiL, O?Reilly M, Halterman MW, Tri-Institutional MD/PhD Conference, Rochester, NY, 1/1/2014
• MKP-1 Effects on HIF-1 (inverted A) in Glioblastoma Multiforme.
  Mills B, Hansen J, and M Halterman, Sensing and Signaling of Hypoxia Symposium; HHMI Peer Cluster Meeting; University Day in Genetics, University of Rochester Medical Center, Rochester, NY, 2013; Beaver Run Resort, Breckenridge, CO, 20, 1/1/2013
• HIF-1(Inverted A) Cleavage in Cerebral Ischemic Injury.
  Mills B, and M Halterman, Pathology Research Day, University of Rochester Medical Center, Rochester, NY, 1/1/2012
• Miningthe MouseGenomeforHypoxia-regulated Proteins Using CD-tagging and Automated Image Analyses
  HaltermanMW, et al, Biomedical Imaging Conference, Howard Hughes Medical Institute, Janelia Farms, 1/1/2009
• DUSP1/MKP-1 Potentiates Hypoxic Cellular Injury and Alters Oxygen-dependent Gene Expression Via Combinatorial Post-Translational Processing of HIF-1a
  Halterman MW, et al, American Neurological Association, 134th Annual meeting, Baltimore, MD, 1/1/2009
• Expression analysis of hypoxia-induced neuron loss reveals distinct roles for the bZIP factors CHOP-10 and ATF4
  Halterman MW, et al, Society for Neuroscience, Washington, DC, 1/1/2009
• Molecular dissection of the cis elements governing the bZIP factor Gadd153/CHOP-10
  Halterman MW, et al, Society for Neuroscience, Washington, DC, 1/1/2009
• Tet-regulated Expression of the p75 Intracellular Domain is Protective Against Oxidant Injury in the HN33 Hippocampal Cell Line
  Halterman MW, et al, American Neurological Association, 132nd Annual meeting, Washington, DC, 1/1/2007
• Join now to see all

Lectures

• Targeting immune-mediated cerebral reperfusion injury in the post cardiac arrest syndrome (PCAS) 
  University of Massachusetts, Worchester, MA, 2017; University of Pittsburgh, Pittsburgh, PA, 2017; N - 1/15/2018
• Priming effects of endotoxemia on neutrophil activation, neuroinflammation and reperfusion injury following transient global ischemia 
  Clearwater Beach, FL - 1/30/2017
•  
  Hamilton College, Clinton, NY - 1/2/2017
• Neuroinflammation (ANA513) 
  1/1/2017
• Introduction & Psychometrics? and ?Measurements III: measuring physical properties 
  1/1/2017
• Stroke: Mechanisms and Emerging Therapeutic Targets 
  1/1/2017
• Immune interventions in stroke 
  University of Rochester, Rochester, NY - 1/1/2016
• Therapeutic Potential of Novel Tetracycline Derivatives in Cerebrovascular Disease 
  Salt Lake City, UT - 1/1/2016
• Perspectives on building a career as an academic neurologist 
  University of Rochester, Rochester, NY, 2013, 2015 - 1/1/2015
• Development of 4th Generation Tetracyclines for Neuroprotection in Cerebrovascular Disease 
  Salt Lake City, UT - 1/1/2015
• The Enemy Within: Neutrophils and the Post Cardiac Arrest Syndrome 
  University of Rochester, Rochester, NY, 2014, 2015 - 1/1/2015
• F30 Applications: From Good to Great 
  University of Rochester, Rochester, NY - 1/1/2014
• Putting the Brakes on HIF-dependent transcription 
  University of Rochester, Rochester, NY - 1/1/2014
• MoleculardissectionofHIF-1dependent signalingin glioblastomamultiforme 
  Rochester, NY - 1/1/2013
• DocCHIRP Mobile App for use in Accountable Care Networks 
  University of Rochester Medical Center, Rochester, NY - 1/1/2013
• Therapeutic target discovery for global ischemic brain injury. 
  University of Rochester, Rochester, NY - 1/1/2012
• From Gene Chips to bZIPs: Using Functional Genomics to Identify Disease-Modifying Genes in Post-Cardiac Arrest Syndrome 
  University of Rochester, Rochester, NY - 1/1/2012
• From Gene Chips to bZIPs: Using Functional Genomics to Define Therapeutic Targets in Global Ischemia. 
  Baltimore, MD, 2011; Mt. Sinai School of Medicine, NY, 2011 - 1/1/2011
• Pathways to Independence ? Implementing your vision for an independent research career 
  University of Rochester School of Medicine - 1/1/2009
• Posterior Circulation Stroke 
  Rochester General Hospital - 1/1/2008
• GBS spectrum disorders 
  Children?s Hospital, University of Cincinnati, Cincinnati, OH - 1/1/2008
• Temporal Analysis of Gene Expression in a Model of Hypoxia-induced Neuronal Apoptosis. 
  Johns Hopkins University, Baltimore, MD - 1/1/2006
• Defining Neurotherapeutic Targets in Hypoxia-induced Signaling Networks. 
  University of Cincinnati, Cincinnati, OH - 1/1/2006
• Hypoxia-induced gene expression controls delayed neuron loss in culture models of stroke 
  University of Michigan, Ann Arbor, MI - 1/1/2006
• Join now to see all